Adam W E
Semin Nucl Med. 1987 Jan;17(1):3-17. doi: 10.1016/s0001-2998(87)80003-x.
New (noninvasive) diagnostic procedures in medicine (ultrasound [US], digital subtraction angiography [DSA], computed tomography [CT], nuclear magnetic resonance [NMR]) create a need for a review of the clinical utility of functional imaging in nuclear medicine. A general approach that is valid for all imaging procedures is not possible. For this reason, an individual assessment for each class of functional imaging is necessary, taking into account the complexity and sophistication of the various imaging procedures. This leads to a hierarchical order: first order functional imaging: imaging of organ motion (heart, lungs, blood); second order functional imaging: imaging of excretory function (kidneys, liver); and third and fourth order functional imaging: imaging of metabolism (except excretory function). First order functional imaging is possible fundamentally, although with limitations in detail, by all modalities. Second order functional imaging is not possible with US. Third and fourth order functional imaging is a privilege of nuclear medicine alone. Up to now, NMR has not proven clinically useful to produce metabolic images in its true sense. This is due to the fact that the signals used are too weak to provide metabolic information with satisfactory local resolution, even after administration of nonradioactive isotopes. First and second order functional imaging of nonradioactive procedures face severe disadvantages, including difficulties in performing stress investigations, which are essential for coronary heart disease, limited capability for true quantitative information (eg, kidney clearance in mL/min), side effects of contrast media and paramagnetic substances, and high costs. Therefore, nuclear medicine functional imaging turns out to be in a favorable clinical position, even in the presence of the competitive diagnostic modalities that have been developed in recent years.
医学中的新型(非侵入性)诊断程序(超声[US]、数字减影血管造影[DSA]、计算机断层扫描[CT]、核磁共振[NMR])使得有必要重新审视核医学中功能成像的临床实用性。不可能有一种适用于所有成像程序的通用方法。因此,考虑到各种成像程序的复杂性和精密性,对每一类功能成像进行单独评估是必要的。这就导致了一种层次顺序:一阶功能成像:器官运动(心脏、肺、血液)成像;二阶功能成像:排泄功能(肾脏、肝脏)成像;三阶和四阶功能成像:代谢(排泄功能除外)成像。一阶功能成像从根本上来说是可行的,尽管在细节上存在局限性,所有模态都可以实现。超声无法进行二阶功能成像。三阶和四阶功能成像仅是核医学的特权。到目前为止,核磁共振尚未在临床上被证明能真正产生代谢图像。这是因为即使在使用非放射性同位素后,所使用的信号仍然太弱,无法以令人满意的局部分辨率提供代谢信息。非放射性程序的一阶和二阶功能成像面临严重的缺点,包括进行应激检查困难(这对冠心病至关重要)、获取真正定量信息的能力有限(例如,肾脏每分钟清除率以毫升计)、造影剂和顺磁性物质的副作用以及成本高昂。因此,即使存在近年来发展起来的具有竞争力的诊断方式,核医学功能成像在临床上仍处于有利地位。